The trading price of Outlook Therapeutics Inc (NASDAQ:OTLK) closed higher on Monday, December 09, and closing at $1.70, 11.84% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $1.53 and $1.8795. In examining the 52-week price action we see that the stock hit a 52-week high of $12.85 and a 52-week low of $0.87. Over the past month, the stock has lost -74.51% in value.
Outlook Therapeutics Inc, whose market valuation is $41.59 million at the time of this writing, is expected to release its quarterly earnings report in January. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest OTLK has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned OTLK a recommendation rating is 5. Out of them, 0 rate it a Hold, while 5 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Outlook Therapeutics Inc (OTLK) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that OTLK’s price is currently -57.07% off the SMA20 and -65.30% off the SMA50. The RSI metric on the 14-day chart is currently showing 21.25, and weekly volatility stands at 15.28%. When measured over the past 30 days, the indicator reaches 17.19%. Outlook Therapeutics Inc (NASDAQ:OTLK)’s beta value is currently sitting at 0.52, while the Average True Range indicator is currently displaying 0.47.
To see how Outlook Therapeutics Inc stock has been performing in comparison to its peers in the industry, here are the numbers: OTLK stock’s performance was 11.84% in the latest trading, and -80.78% in the past year.
An evaluation of the daily trading volume of Outlook Therapeutics Inc (NASDAQ:OTLK) indicates that the 3-month average is 1.55 million. However, this figure has increased over the past 10 days to an average of 8.4.
Currently, records show that 23.41 million of the company’s shares remain outstanding. The insiders hold 35.60% of outstanding shares, whereas institutions hold 35.70%. The stats also highlight that short interest as of 2024-11-15, stood at 3.4 million shares, resulting in a short ratio of 11.43 at that time. From this, we can conclude that short interest is 2115.00 of the company’s total outstanding shares. It is noteworthy that short shares in November were up slightly from the previous month’s figure, which was 2.99 million. However, since the stock’s price has seen -78.43% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
